Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination
| No. | 27 |
|---|---|
| Citation | J Thromb Haemost 15,p538-548(2017) |
| Institute | Fujita Health University school of Health Science |
| 1st Author | T Matsui |
| AR | |
| PL | ○ |
| HD | |
| Paper types | Basic science |
| Main purpose | Evaluation of mutant protein efficacy |
| Disease | |
| Antiplatelet drug | |
| Anticoagulant drug | |
| Other drug | |
| Clinical specimens | |
| Animal | |
| Keyword | vWF, Botrocetin |